Study of Biostate for Treatment of Children With Hemophilia A Complicated by Antibody Development

PHASE3TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions

Hemophilia A

Interventions

BIOLOGICAL

Biostate

200 IU/kg administered daily

Trial Locations (7)

Study Site, Vienna

Study Site, Frankfurt

Study Site, Hamburg

Study Site, Athens

Study Site, Thessaloniki

Study Site, Milan

Study Site, Barnaul